Capital Research Global Investors
DXCM icon

Capital Research Global Investors’s DexCom DXCM Stock Holding History

Capital Research Global Investors’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,367,676
Closed -$159M – 442
2025
Q3 		$159M Sell
2,367,676
-3,038,943
-56% -$240M 0.03% 245
2025
Q2 		$472M Sell
5,406,619
-6,630,079
-55% -$520M 0.09% 146
2025
Q1 		$822M Sell
12,036,698
-2,335,053
-16% -$191M 0.18% 110
2024
Q4 		$1.12B Sell
14,371,751
-3,576,503
-20% -$265M 0.23% 96
2024
Q3 		$1.2B Buy
17,948,254
+6,002,727
+50% +$493M 0.25% 89
2024
Q2 		$1.35B Sell
11,945,527
-1,490,365
-11% -$188M 0.3% 75
2024
Q1 		$1.86B Sell
13,435,892
-1,860,140
-12% -$234M 0.42% 56
2023
Q4 		$1.9B Buy
15,296,032
+2,695,296
+21% +$275M 0.47% 58
2023
Q3 		$1.18B Buy
12,600,736
+3,484,190
+38% +$393M 0.32% 77
2023
Q2 		$1.17B Sell
9,116,546
-158,069
-2% -$19.1M 0.31% 78
2023
Q1 		$1.08B Sell
9,274,615
-186,930
-2% -$20.9M 0.31% 81
2022
Q4 		$1.07B Sell
9,461,545
-1,068,693
-10% -$117M 0.32% 79
2022
Q3 		$848M Buy
10,530,238
+2,847,171
+37% +$241M 0.28% 90
2022
Q2 		$573M Sell
7,683,067
-2,886,973
-27% -$263M 0.18% 112
2022
Q1 		$1.35B Buy
10,570,040
+1,071,860
+11% +$117M 0.33% 75
2021
Q4 		$1.28B Buy
9,498,180
+3,379,664
+55% +$486M 0.28% 88
2021
Q3 		$836M Buy
6,118,516
+392,136
+7% +$49.5M 0.2% 113
2021
Q2 		$611M Buy
5,726,380
+4,144,828
+262% +$398M 0.14% 142
2021
Q1 		$142M Buy
+1,581,552
New +$148M 0.03% 273
2018
Q4 		– Sell
-1,440,000
Closed -$51.5M – 418
2018
Q3 		$51.5M Buy
+1,440,000
New +$44.6M 0.02% 332

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JSC
J. Stern & Co London, United Kingdom $1.03B AUM 20.71% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Capital Research Global Investors's DXCM Position: Q4 2025 in Review

Capital Research Global Investors sold out of DexCom (DXCM) in Q4 2025, closing a stake of 2,367,676 shares — an estimated $159M sold.

Capital Research Global Investors first reported a position in DXCM in Q3 2018 and held it in 20 quarters. The position peaked at $1.9B in Q4 2023. 921 funds tracked by Wall St. Rank hold DXCM as of Q4 2025.

  • Capital Research Global Investors reported no remaining DexCom position as of Q4 2025 after selling out during the quarter.
  • Capital Research Global Investors sold 2,367,676 DexCom shares in Q4 2025, an estimated $159M.
  • Capital Research Global Investors first reported a position in DexCom in Q3 2018 and held it in 20 quarters.
  • Capital Research Global Investors's DexCom position peaked at $1.9B in Q4 2023.
  • 921 funds tracked by Wall St. Rank held DexCom as of Q4 2025.

Based on Capital Research Global Investors's 13F filing for Q4 2025, filed 11 Feb 2026.